discovery of glp-1 Frontiers Understanding GLP-1 receptor agonists and

A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe

The lack of significant differences in well-being indices and anxiety and depression scores between the two groups may be attributable to numerous confounding psychological factors, strong patient heterogeneity, small sample size, and short follow-up duration

Research, C

What Actually Supports People Using GLP-1 Medications GLP-1 medications can meaningfully change appetite, meal size, and digestion

However, results can vary depending on the individual

Mutations in the PRPS1 gene are those that are associated with PRPP synthetase superactivity